Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,539 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
THEMIS is a substrate and allosteric activator of SHP1, playing dual roles during T cell development.
Zhang J, Jiang Z, Zhang X, Yang Z, Wang J, Chen J, Chen L, Song M, Zhang Y, Huang M, Chen S, Xiong X, Wang Y, Hao P, Horng T, Zhuang M, Zhang L, Zuo E, Bai F, Zheng J, Wang H, Fan G. Zhang J, et al. Among authors: huang m. Nat Struct Mol Biol. 2024 Jan;31(1):54-67. doi: 10.1038/s41594-023-01131-3. Epub 2024 Jan 4. Nat Struct Mol Biol. 2024. PMID: 38177672
Effectiveness of digital modified behavioral activation treatment program for rural older adults with depressive symptoms in Western Hunan: study protocol for a multi-center randomized controlled trial.
Luo Y, Wang J, Gan G, Liu M, Lu Z, Jia S, Huang M, Wang S, Gan M, Xie J, Cheng ASK. Luo Y, et al. Among authors: huang m. BMC Psychol. 2024 Dec 25;12(1):783. doi: 10.1186/s40359-024-02215-5. BMC Psychol. 2024. PMID: 39722075 Free article. Clinical Trial.
Decoding cancer etiology with cellular reprogramming.
Huang MF, Fisher ME, Phan TTT, Zhao R, Lee DF. Huang MF, et al. Curr Opin Genet Dev. 2024 Dec 24;90:102301. doi: 10.1016/j.gde.2024.102301. Online ahead of print. Curr Opin Genet Dev. 2024. PMID: 39721322 Review.
A phase II trial of larotrectinib in tumors with NTRK fusions or extremes of NTRK mRNA overexpression identified by comprehensive genomic profiling.
Thavaneswaran S, Sim HW, Grady J, Espinoza D, Huang ML, Lin F, McGrath M, Desai J, Charakidis M, Brown M, Kansara M, Simes J, Thomas D. Thavaneswaran S, et al. Among authors: huang ml. Oncologist. 2024 Dec 25:oyae339. doi: 10.1093/oncolo/oyae339. Online ahead of print. Oncologist. 2024. PMID: 39720993 Free article.
18,539 results
You have reached the last available page of results. Please see the User Guide for more information.